Tissue Analytics, with their launch of an EHR-Interoperable Marketplace for wound care diagnostic and preventive devices, announces collaborative partnership with Kent Imaging.

This partnership allows physicians to quickly and easily assess tissue viability and track wound healing progression when advanced wound care therapies are applied. Kent’s CEO, Pierre Lemire, is states “An open API from Tissue Analytics provides a key framework where tissue oxygenation images captured with SnapshotNIR can be combined with wound data from other vendors to enhance wound comprehension and impact decision making. This improves the clinically relevant data that is required to assess and manage wounds.” 

Tissue-Analytics-Kent-Imaging-PR

Kent Imaging is honoured in Acquisition International’s (AI) annual Global Excellence Awards as the “Most Innovative Medical Imaging Technology Developer – Canada.”

AI is a UK-based international, monthly, digital business magazine dedicated to delivering vital updates to their corporate readers. The annual Business Excellence Awards winners are hand-picked by AI’s expert judges based on commitment to client service and excellence in their respective sectors. Tissue viability is a key factor in wound healing, and tissue oxygen levels are the best biomarker for predicting this. SnapshotNIR, utilizing near infrared spectroscopy (NIRS) imaging, provides a comprehensive measure of the hemoglobin oxygen saturation of the microvascular bed within the capillaries. The clinically relevant oxygen data captured is then used to assess the wound and impact the treatment choices for better wound management. 

AI-Magazine-Issue-10-2019-Aug19383

Easy-to-operate SnapshotNIR valuable in tracking wound healing progress with PACE therapy.

Dr. Windy Cole DPM, Kent State University, uses SnapshotNIR to assess chronic wound healing in a pulsed acoustic cellular expression (PACE) therapy case study. SnapshotNIR was shown to be “a very user friendly point-of-care imaging device to track weekly wound progress. It provided an objective means of evaluating wound response to PACE therapy.” Published in Today’s Wound Clinic® October 2019.

TWC1019_Cole